This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older